Core Viewpoint - UBS has raised its profit forecasts for Hengan International (01044) for 2025 to 2027 by 1% to 4%, and revenue forecasts by 1% to 2%, with the target price increased from HKD 27.7 to HKD 29.5, maintaining a "Buy" rating [1] Financial Performance - For the first half of 2025, Hengan's revenue and net profit decreased by 0.2% and 2.6% respectively, with an expected net profit decline of approximately 12% when excluding foreign exchange gains, which is largely in line with UBS's expectations [1] - Tissue paper business revenue grew by 3% year-on-year, while sanitary napkin revenue fell by 14% [1] Management Insights - Management indicated that the performance of wet wipes is stable, and the competitive landscape in the tissue paper market is better than expected, but sales of sanitary products and mid-to-low-end diapers have declined due to intensified competition [1] Future Outlook - The group anticipates steady growth in tissue paper sales, and an improvement in gross margins for sanitary products in the second half of 2025 [1]
瑞银：维持恒安国际“买入”评级 目标价升至29.5港元